ข่าวประชาสัมพันธ์ Neurim+Pharmaceuticals+Piromelatine
Bayer Pharmaceuticals poised for landmark year with significant pipeline progress and blockbuster launches
Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma Media Day in Berlin, Germany. As part of the ongoing transformation of its pharmaceutical business, Bayer has made significant investments in R&D to accelerate medical innovations and build a highly differentiated pipeline for long-term growth across key therapeutic areas, including oncology, cardiovascular diseases, neurology and rare diseases, and immunology. Bayer is